This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

£200 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
4 - 6 June, 2024
Excel London Platinum Suite

Konrad Krawczyk, PhD
CEO at NaturalAntibody


Konrad Krawczyk has more than a decade experience in developing databases and computational models for therapeutic antibody discovery, contributing to Oxford University resources such as SAbDab/SAbPred platform and the Observed Antibody Space, that are used widely by academia and industry. He is the founder of NaturalAntibody that focuses on building computational/machine learning tools to accelerate therapeutic antibody discovery.

Agenda Sessions

  • Comprehensive Benchmarking of Computational/ML Discovery Protocols: The Benefits and Pitfalls for Biologics Discovery